InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.64
(
0.77%
)
US TECH 100
19,449.20
(
1.47%
)
Dow Jones
38,768.10
(
0.46%
)
Brent Oil
83.90
(
2.16%
)
Bitcoin
66,604.60
(
-0.05%
)
Post# of 252227
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: biotech jim post# 144711

Friday, 06/29/2012 10:14:27 AM

Friday, June 29, 2012 10:14:27 AM

Post# of 252227
The most advanced GPR119 receptor agonistis in the clinic I could find now for type 2 diabetes is PSN821 (licensed to AZN). Seems that few big players (JNJ, SNY GSK) abandoned their candidates after phase II or earlier (from the limited data I've seen, guess on efficacy).

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up